PALATIN TECHNOLOGIES

PTN
Delayed Quote. Delayed  - 10/27 04:10:00 pm
0.4181USD -0.95%

Turn to zoom
Prev.0.4221
Open0.4225
High0.4340
Low0.4125
Volume896 175
Latest news
09/29
09/29
09/29
09/28
Chart PALATIN TECHNOLOGIES, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance0,450,520,70
Spread/Res.-6,7%-20%-40%
Spread/Supp.1,9%1,9%0,99%
Support0,410,410,41
Financials
Sales 2022 2,25 M - -
Net income 2022 -36,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 -2,79x
Yield 2022 -
Capitalization 96,7 M 96,7 M -
Capi. / Sales 2022 43,0x
Capi. / Sales 2023 13,5x
Nbr of Employees 26
Free-Float 95,6%
Company
Palatin Technologies, Inc. (Palatin), is a biopharmaceutical company. Palatin is focused on developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Palatin product candidates are targeted receptor-specific therapeutics for the...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-11-16 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 0,42 $
Average target price 2,33 $
Spread / Average Target 458%